Ben Sasse, the former Republican U.S. Senator and past president of the University of Florida, has provided a harrowing update on his terminal stage 4 pancreatic cancer diagnosis, revealing that while experimental treatments have significantly shrunk his tumors, his prognosis remains a “death sentence.”
In a candid interview on The New York Times podcast with Ross Douthat, the 54-year-old statesman appeared with visible facial wounds—a side effect of an aggressive clinical trial drug—to discuss his mortality and his decision to spend his remaining months in the public eye.
Sasse’s medical crisis began in late October 2025. An avid athlete, Sasse initially dismissed severe abdominal and back pain as a training injury sustained during sprint triathlon preparation. By November, the pain became debilitating.
Following a series of inconclusive tests for gastrointestinal issues, a full-body scan in December 2025 revealed the gravity of the situation. Doctors informed Sasse his torso was “chock-full of tumors.” The cancer had already metastasized to his lungs, liver, and vascular system, involving at least five distinct areas of the body.
Sasse is currently participating in clinical trials in Houston, Texas, utilizing an oral drug called daraxonrasib. While the medication has successfully reduced the size of his tumors by 76% since December, the physiological toll is immense.
“My body can’t grow skin and so I bleed all out of a whole bunch of parts of me that shouldn’t be bleeding,” Sasse told Douthat.
Beyond the bleeding, Sasse’s daily regimen involves intense pain management and nausea control. Though he previously required 55 milligrams of morphine daily, he has recently lowered his dosage to 30 milligrams as his pain levels have decreased by roughly 80%.
Despite the significant tumor shrinkage, Sasse remains clear-eyed about the terminal nature of his condition. He likened the treatment to a game of “Whac-A-Mole,” noting that even as existing tumors retreat, new ones inevitably emerge. When asked if recovery was possible for his specific condition, Sasse replied, “Not from what I have, no.”
:max_bytes(150000):strip_icc():focal(749x0:751x2):format(webp)/ben-sasse-010826-5-de47746ee2234835940b4bcc02a780ee.jpg)
Sasse, a father of three, stated that his public transparency is driven by a desire to “redeem the time” and impart final wisdom to his children and the public.
“I’m doing a heck of a lot better than I was doing at Christmas,” Sasse said, noting he has already outlived the initial three-month life expectancy he received in December. He currently resides in Austin to be near friends while commuting to Houston for ongoing treatment.
